Announcements

Serge Saxonov, Chief Executive Officer and Director of 10x Genomics, Inc. (NASDAQ:TXG), filed a Form 4 on September 3, 2026, reporting a change in beneficial ownership of Class A Common Stock with a transaction dated September 1, 2026.

Director John B. Veihmeyer filed a Form 4 with the U.S. Securities and Exchange Commission on September 3, 2026, reporting the crediting of dividend equivalents as Restricted Stock Units in Ford Motor Co (NYSE:F) on September 1, 2026.

A Form 4 filed on September 3, 2026 discloses that John S. Weinberg, a director of Ford Motor Co, received credits of dividend equivalent Restricted Stock Units on September 1, 2026 under two separate non-employee director stock plans.

Tyler Sloat, Chief Financial and Operating Officer of Freshworks Inc. (NASDAQ:FRSH), filed a Form 4 on September 3, 2026, disclosing four transactions on September 1, 2026, in which shares of Class A Common Stock were withheld to satisfy tax obligations tied to vesting restricted …

Freshworks Inc. CEO and President Dennis Woodside filed a Form 4 on September 3, 2026, reporting five share dispositions on September 1, 2026, all representing Class A Common Stock withheld to satisfy tax obligations tied to vesting restricted stock units.

Ryan Manning, Chief Product and Tech Officer of Freshworks Inc., filed a Form 4 on September 3, 2026, disclosing the acquisition of 1,162,790 restricted stock units on September 1, 2026, under the company's 2022 Inducement Plan.

Wendy Short Bartie, Executive Vice President of Corporate Affairs at Bristol Myers Squibb, filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a related tax-withholding disposition of common stock on September 1, 2026.